About Us
“Why isn’t there a better solution for period pain?”
Conversations with friends, colleagues and women in my life revealed the same story: frustration with existing options and a quiet resignation that suffering with period pain was just part of being female. The more I listened, the more I realized how under-recognized and stigmatized period pain still is. When I asked my brother Benjamin, a gynecologist, why nothing better existed, his response was plain: “If men had periods, this would’ve been solved already”. That moment crystallised my mission.
I founded Meliodays on the belief that we can build a different kind of solution. One that’s rooted in science, accountability, and informed by women’s lived experience. Alongside Benjamin, Martin, and the rest of the team, we are building a new period pain solution because chronic conditions such as period pain are a result of systemic neglect, and it only ends when we start building better.
With Love,
Simone
Co-Founder & CEO
Felt by millions.
Believed by few.
Period pain is one of the biggest blind spots in healthcare.
Women deserve better health outcomes, and we are committed to changing that. Women’s health has been chronically underfunded, under-researched, and undervalued. This injustice has left an innovation gap that too often compromises care.
Our journey begins with menstrual health not only because it affects over 80% of women globally, but because it remains one of the most underrecognized and undertreated health issues in modern medicine. It is a chronic condition with a long-term psychological impact, and it leaves millions to suffer in silence with no support or long-term relief.
We are Meliodays.
We want to create a world where women have a say in our health and access to innovative, research-backed solutions designed by and with women, not just adapted to women.
Melio means better, and days mean the days of our lives.
Better days are coming.
Meliodays.
Meet the Team
-
Simone Sabbione
Co-Founder & CEO
Former CHRO who scaled an automotive start-up from 5 to 400+ employees and to a NASDAQ IPO. Now leading Meliodays to close the gender health gap.
-
Martin Sabbione
Co-Founder & CFO
Venture capital and finance professional. Focused on fundraising, governance, and financial strategy for Meliodays. -
Dr. Benjamin Wolf
Co-Founder & CSO
Gynecologist, professor at Leipzig University, and postdoctoral researcher at Harvard Medical School. Brings academic and clinical insight to MelioOne®’s development. -
Dr. Eda Celikbas
VP Research & Development
Biomedical engineer and Chemistry PhD with 8+ years’ research experience developing functional materials for cancer theranostics. Author of 17 peer-reviewed publications, now translating polymer science into next-generation uterine therapeutics at Meliodays. -
Karl Gevers
VP Finance & Investor Relations
Chartered Accountant and ex-founder with a background in financial operations, asset and fund management. Manages capital allocation, growth strategy, and operational finance structures to de-risk development and investor entry.
-
Trudy Au
VP Brand Marketing & Comms
Brand strategist who launched and scaled nine markets, supporting an airline’s growth from 2,000 to 20,000 employees. Brings expertise in brand management, global campaigns, and crisis communication to Meliodays.
Advisory Board
-
Milana Keaty
Strategic Advisor
Milana brings 25+ years of leadership experience in the pharmaceutical industry with deep expertise in Women’s Health and commercialization of innovative therapies.
-
Richard Gerstenberg
Strategic Advisor
Richard Gerstenberg is an international Strategy & Transformation executive with 30+ years in life sciences, specializing in Licensing, M&A, and post-acquisition integration.